Buse Aysen Dundar

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Advanced Non Small Cell Lung Cancer

Molecular Docking

Tyrosine Kinase

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Harika Atmaca, Suleyman Ilhan, Çisil Çamli Pulat, Buse Aysen Dundar, Metin Zora
Evaluation of Novel Spiro-pyrrolopyridazine Derivatives as Anticancer Compounds: In Vitro Selective Cytotoxicity, Induction of Apoptosis, EGFR Inhibitory Activity, and Molecular Docking Analysis. ACS omega 9 (22) (2024)
Harika Atmaca, Suleyman Ilhan, Çisil Çamli Pulat, Buse Aysen Dundar, Metin Zora
Evaluation of Novel Spiro-pyrrolopyridazine Derivatives as Anticancer Compounds: In Vitro Selective Cytotoxicity, Induction of Apoptosis, EGFR Inhibitory Activity, and Molecular Docking Analysis. ACS omega 9 (22) (2024)